{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:41:01Z","timestamp":1793245261594,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"George J. and Angelina P. Kostas Charitable Foundation"},{"name":"William Randolph Hearst Foundation"},{"name":"Cullen Trust for Health Care Foundation"},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["# RP170466"],"award-info":[{"award-number":["# RP170466"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Associazone Bianca Garavaglia Onlus","award":["A\/15\/01O"],"award-info":[{"award-number":["A\/15\/01O"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biomaterials.2017.09.020","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T21:45:16Z","timestamp":1506116716000},"page":"155-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":262,"special_numbering":"C","title":["Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery"],"prefix":"10.1016","volume":"147","author":[{"given":"Alessandro","family":"Parodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Sushnitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan O.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Arrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Tasciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40089-014-0094-7","article-title":"Nanomedicine and drug delivery: a mini review","volume":"4","author":"Mirza","year":"2014","journal-title":"Int. Nano Lett."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J.\u00a0Control. Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2017.09.020_bib3","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"issue":"31","key":"10.1016\/j.biomaterials.2017.09.020_bib4","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s11434-012-5387-5","article-title":"Multifunctional to multistage delivery systems: the evolution of nanoparticles for biomedical applications","volume":"57","author":"Martinez","year":"2012","journal-title":"Chin. Sci. Bull."},{"issue":"17","key":"10.1016\/j.biomaterials.2017.09.020_bib5","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1021\/acsami.6b13760","article-title":"Enhancing vascularization through the controlled release of platelet-derived growth factor-BB","volume":"9","author":"Minardi","year":"2017","journal-title":"ACS Appl. Mater Interfaces"},{"issue":"11","key":"10.1016\/j.biomaterials.2017.09.020_bib6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2217\/nnm-2017-0401","article-title":"Nanoantibiotics: a new paradigm for the treatment of surgical infection","volume":"12","author":"Fernandez-Moure","year":"2017","journal-title":"Nanomedicine Lond"},{"issue":"14","key":"10.1016\/j.biomaterials.2017.09.020_bib7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2174\/1389450115666141015113914","article-title":"Multistage nanovectors enhance the delivery of free and encapsulated drugs","volume":"16","author":"Martinez","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.colsurfb.2015.10.005","article-title":"Multistage vector delivery of sulindac and silymarin for prevention of colon cancer","volume":"136","author":"Scavo","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1166\/jnn.2017.12623","article-title":"Ghee butter as a therapeutic delivery system","volume":"17","author":"Balasubramanian","year":"2017","journal-title":"J.\u00a0Nanosci. Nanotechnol."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.copbio.2013.02.020","article-title":"Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications","volume":"24","author":"Rizzo","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2014.03.056","article-title":"Breakthrough discoveries in drug delivery technologies: the next 30years","volume":"190","author":"Brambilla","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib12","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S46900","article-title":"Nanopharmaceuticals (part 1): products on the market","volume":"9","author":"Weissig","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/IJN.S65526","article-title":"Nanopharmaceuticals (part 2): products in the pipeline","volume":"10","author":"Weissig","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"03","key":"10.1016\/j.biomaterials.2017.09.020_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1557\/mrs.2014.29","article-title":"Clinical translational challenges in nanomedicine","volume":"39","author":"Sengupta","year":"2014","journal-title":"MRS Bull."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2012.09.038","article-title":"Cancer nanomedicines: so many papers and so few drugs","volume":"65","author":"Venditto","year":"2013","journal-title":"Adv. drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib16","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1021\/nn404501g","article-title":"Facing the truth about nanotechnology in drug delivery","volume":"7","author":"Park","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib17","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/nnm.15.188","article-title":"The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery","volume":"11","author":"Corbo","year":"2016","journal-title":"Nanomedicine Lond.d)"},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib19","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1021\/acsnano.7b00376","article-title":"Unveiling the in\u00a0vivo protein corona of circulating leukocyte-like carriers","volume":"11","author":"Corbo","year":"2017","journal-title":"ACS Nano"},{"issue":"37","key":"10.1016\/j.biomaterials.2017.09.020_bib20","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1016\/j.biomaterials.2014.08.024","article-title":"The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation","volume":"35","author":"Martinez","year":"2014","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2017.09.020_bib21","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/nn502807n","article-title":"Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix","volume":"8","author":"Parodi","year":"2014","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.biomaterials.2017.09.020_bib22","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2217\/nnm.15.39","article-title":"Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers","volume":"10","author":"Parodi","year":"2015","journal-title":"Nanomedicine Lond.d)"},{"issue":"19","key":"10.1016\/j.biomaterials.2017.09.020_bib23","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2217\/nnm.15.133","article-title":"Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials","volume":"10","author":"Yazdi","year":"2015","journal-title":"Nanomedicine Lond."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib24","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s11095-011-0453-2","article-title":"Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system","volume":"28","author":"De Rosa","year":"2011","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"28","key":"10.1016\/j.biomaterials.2017.09.020_bib26","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/adma.201202080","article-title":"Materials for drug delivery: innovative solutions to address complex biological hurdles","volume":"24","author":"Mitragotri","year":"2012","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0955-0674(00)00253-2","article-title":"Leukocyte transendothelial migration: orchestrating the underlying molecular machinery","volume":"13","author":"Worthylake","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.copbio.2013.02.013","article-title":"Bioinspired drug delivery systems","volume":"24","author":"Alvarez-Lorenzo","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2017.09.020_bib29","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1039\/C4NJ00864B","article-title":"Bioinspired nanoarchitectonics as emerging drug delivery systems","volume":"38","author":"Ariga","year":"2014","journal-title":"New J. Chem."},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.tibtech.2015.07.001","article-title":"Biomimetic particles as therapeutics","volume":"33","author":"Meyer","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/nnm-2016-0374","article-title":"Bioinspired approaches for cancer nanotheranostics","volume":"12","author":"Evangelopoulos","year":"2017","journal-title":"Nanomedicine Lond.d)"},{"issue":"13","key":"10.1016\/j.biomaterials.2017.09.020_bib32","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/adfm.200600361","article-title":"Biomimetic hydroxyapatite\u2013drug nanocrystals as potential bone substitutes with antitumor drug delivery properties","volume":"17","author":"Palazzo","year":"2007","journal-title":"Adv. Funct. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2017.09.020_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.tibtech.2015.09.005","article-title":"Advances in dental materials through nanotechnology: facts, perspectives and toxicological aspects","volume":"33","author":"Padovani","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib34","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1166\/jnn.2017.13885","article-title":"Applications of nanomaterials in dental science: a review","volume":"17","author":"Sharan","year":"2017","journal-title":"J.\u00a0Nanosci. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biomaterials.2016.01.052","article-title":"One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA","volume":"87","author":"Khaled","year":"2016","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biomaterials.2017.09.020_bib36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering targeted viral vectors for gene therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral vectors for gene therapy: translational and clinical outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/ar2002232","article-title":"Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise","volume":"45","author":"Wagner","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/nnm.11.104","article-title":"Chemotherapy targeting by DNA capture in viral protein particles","volume":"7","author":"Agadjanian","year":"2012","journal-title":"Nanomedicine Lond.d)"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib41","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1021\/acsnano.5b07360","article-title":"Tobacco mosaic virus delivery of phenanthriplatin for cancer therapy","volume":"10","author":"Czapar","year":"2016","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.copbio.2004.10.002","article-title":"Virus-like particles as vaccines and vessels for the delivery of small molecules","volume":"15","author":"Garcea","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib43","doi-asserted-by":"crossref","first-page":"21803","DOI":"10.1038\/srep21803","article-title":"Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles","volume":"6","author":"Abraham","year":"2016","journal-title":"Sci. Rep."},{"issue":"41","key":"10.1016\/j.biomaterials.2017.09.020_bib44","doi-asserted-by":"crossref","first-page":"16998","DOI":"10.1073\/pnas.1101874108","article-title":"Protein delivery using engineered virus-like particles","volume":"108","author":"Kaczmarczyk","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib45","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1021\/nn201397z","article-title":"Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles","volume":"5","author":"Ashley","year":"2011","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib46","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/nl060378g","article-title":"Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid","volume":"6","author":"Anderson","year":"2006","journal-title":"Nano Lett."},{"issue":"9\u201310","key":"10.1016\/j.biomaterials.2017.09.020_bib47","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/smll.201401952","article-title":"Efficient encapsulation of Fe(3)O(4) nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications","volume":"11","author":"Shen","year":"2015","journal-title":"Small"},{"issue":"5649","key":"10.1016\/j.biomaterials.2017.09.020_bib48","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1090284","article-title":"Three-dimensional structure of herpes simplex virus from cryo-electron tomography","volume":"302","author":"Grunewald","year":"2003","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.biomaterials.2017.09.020_bib49","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1002\/adma.201302737","article-title":"Nanoparticles mimicking viral surface topography for enhanced cellular delivery","volume":"25","author":"Niu","year":"2013","journal-title":"Adv. Mater."},{"issue":"12 Suppl","key":"10.1016\/j.biomaterials.2017.09.020_bib50","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"22","key":"10.1016\/j.biomaterials.2017.09.020_bib52","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1002\/anie.201007829","article-title":"Viral-capsid-type vesicle-like structures assembled from M12L24 metal-organic hybrid nanocages","volume":"50","author":"Li","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ddr.20062","article-title":"Polymersomes as viral capsid mimics","volume":"67","author":"Ahmed","year":"2006","journal-title":"Drug Dev. Res."},{"issue":"52","key":"10.1016\/j.biomaterials.2017.09.020_bib54","doi-asserted-by":"crossref","first-page":"17902","DOI":"10.1021\/ja507833x","article-title":"Structural mimics of viruses through peptide\/DNA co-assembly","volume":"136","author":"Ni","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/smll.201301885","article-title":"Smart nanovehicles based on pH-triggered disassembly of supramolecular peptide-amphiphiles for efficient intracellular drug delivery","volume":"10","author":"Xu","year":"2014","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.biomaterials.2017.09.020_bib56","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/adma.201304592","article-title":"Viral mimicking ternary polyplexes: a reduction-controlled hierarchical unpacking vector for gene delivery","volume":"26","author":"He","year":"2014","journal-title":"Adv. Mater"},{"issue":"8","key":"10.1016\/j.biomaterials.2017.09.020_bib57","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1021\/bm900370p","article-title":"Virus-inspired approach to nonviral gene delivery vehicles","volume":"10","author":"Roy","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib58","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/ncomms2905","article-title":"An influenza virus-inspired polymer system for the timed release of siRNA","volume":"4","author":"Truong","year":"2013","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.biomaterials.2017.09.020_bib59","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1002\/adfm.201502049","article-title":"Virus-inspired mimics based on dendritic lipopeptides for efficient tumor-specific infection and systemic drug delivery","volume":"25","author":"Zhang","year":"2015","journal-title":"Adv. Funct. Mater"},{"issue":"13","key":"10.1016\/j.biomaterials.2017.09.020_bib60","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/anie.200704121","article-title":"A\u00a0virus-mimetic nanogel vehicle","volume":"47","author":"Lee","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0854.2002.30502.x","article-title":"The biogenesis and functions of exosomes","volume":"3","author":"Stoorvogel","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","article-title":"Using exosomes, naturally-equipped nanocarriers, for drug delivery","volume":"219","author":"Batrakova","year":"2015","journal-title":"J.\u00a0Control. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib63","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.2010.278","article-title":"Exosomes\/microvesicles as a mechanism of cell-to-cell communication","volume":"78","author":"Camussi","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2016.02.037","article-title":"Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity","volume":"228","author":"Ferguson","year":"2016","journal-title":"J.\u00a0Control. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2017.09.020_bib65","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1021\/pr8004887","article-title":"Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes","volume":"7","author":"Conde-Vancells","year":"2008","journal-title":"J.\u00a0proteome Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(81)90512-5","article-title":"Exfoliation of membrane ecto-enzymes in the form of micro-vesicles","volume":"645","author":"Trams","year":"1981","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembranes"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-1759(02)00330-7","article-title":"Production and characterization of clinical grade exosomes derived from dendritic cells","volume":"270","author":"Lamparski","year":"2002","journal-title":"J.\u00a0Immunol. methods"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib69","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J.\u00a0Extracell. vesicles"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-61779-068-3_15","article-title":"Exosome isolation for proteomic analyses and RNA profiling","author":"Taylor","year":"2011","journal-title":"Serum\/Plasma Proteomics Methods Protoc."},{"issue":"11","key":"10.1016\/j.biomaterials.2017.09.020_bib71","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1039\/C5LC00240K","article-title":"Exosome isolation: a microfluidic road-map","volume":"15","author":"Liga","year":"2015","journal-title":"Lab a Chip"},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."},{"issue":"23","key":"10.1016\/j.biomaterials.2017.09.020_bib73","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.18632\/oncotarget.4004","article-title":"Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death","volume":"6","author":"Raimondo","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib74","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/eji.200535501","article-title":"Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells","volume":"36","author":"Chen","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","article-title":"Exosomes and cardiac repair after myocardial infarction","volume":"114","author":"Sahoo","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib76","doi-asserted-by":"crossref","first-page":"e66393","DOI":"10.1371\/journal.pone.0066393","article-title":"MicroRNAs involved in regulating spontaneous recovery in embolic stroke model","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib77","first-page":"75","article-title":"A\u00a0comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy","volume":"1846","author":"Johnsen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib78","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib79","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biotechadv.2012.08.008","article-title":"Exosomes for drug delivery\u2014a novel application for the mesenchymal stem cell","volume":"31","author":"Lai","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-59745-324-0_9","article-title":"Permeabilization of cell membranes","author":"Jamur","year":"2010","journal-title":"Immunocytochemical methods Protoc."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib81","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in\u00a0vitro tumor growth: a new approach for drug delivery","volume":"192","author":"Pascucci","year":"2014","journal-title":"J.\u00a0Control. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib82","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/0008-5472.CAN-07-3163","article-title":"Targeting tumor antigens to secreted membrane vesicles in\u00a0vivo induces efficient antitumor immune responses","volume":"68","author":"Zeelenberg","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-11-88","article-title":"Exosomes are natural carriers of exogenous siRNA to human cells in\u00a0vitro","volume":"11","author":"Shtam","year":"2013","journal-title":"Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2014.02.007","article-title":"Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration","volume":"445","author":"Shimbo","year":"2014","journal-title":"Biochem. biophys. Res. Commun."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2016.01.028","article-title":"PLK-1 silencing in bladder cancer by siRNA delivered with exosomes","volume":"91","author":"Greco","year":"2016","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib86","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A\u00a0doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib87","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A\u00a0novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib88","series-title":"Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue","author":"Clinicaltrialsgov","year":"2017"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib89","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.actbio.2017.05.013","article-title":"Augmented liver targeting of exosomes by surface modification with cationized pullulan","volume":"57","author":"Tamura","year":"2017","journal-title":"Acta Biomater."},{"issue":"15","key":"10.1016\/j.biomaterials.2017.09.020_bib90","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1021\/jacs.7b00319","article-title":"Molecular recognition-based DNA nanoassemblies on the surfaces of nanosized exosomes","volume":"139","author":"Wan","year":"2017","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.biomaterials.2017.09.020_bib91","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bc500291r","article-title":"Surface functionalization of exosomes using click chemistry","volume":"25","author":"Smyth","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib92","first-page":"1525","article-title":"Exosome mimetics: a novel class of drug delivery systems","volume":"7","author":"Kooijmans","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"10","key":"10.1016\/j.biomaterials.2017.09.020_bib93","doi-asserted-by":"crossref","first-page":"e47480","DOI":"10.1371\/journal.pone.0047480","article-title":"Exosomal lipids impact notch signaling and induce death of human pancreatic tumoral SOJ-6 cells","volume":"7","author":"Beloribi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib94","doi-asserted-by":"crossref","first-page":"21933","DOI":"10.1038\/srep21933","article-title":"Engineering hybrid exosomes by membrane fusion with liposomes","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"issue":"7203","key":"10.1016\/j.biomaterials.2017.09.020_bib95","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10623320213631","article-title":"Endothelial cells at inflammatory sites as target for therapeutic intervention","volume":"9","author":"Koning","year":"2002","journal-title":"Endothelium"},{"issue":"11","key":"10.1016\/j.biomaterials.2017.09.020_bib97","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib98","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4330\/wjc.v6.i6.462","article-title":"Antioxidants, inflammation and cardiovascular disease","volume":"6","author":"Mangge","year":"2014","journal-title":"World J. Cardiol."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib99","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10787-012-0124-x","article-title":"Inflammation in neurological and psychiatric diseases","volume":"20","author":"Khansari","year":"2012","journal-title":"Inflammopharmacology"},{"issue":"8","key":"10.1016\/j.biomaterials.2017.09.020_bib100","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.drudis.2015.02.006","article-title":"An analysis of FDA-approved drugs for inflammation and autoimmune diseases","volume":"20","author":"Kinch","year":"2015","journal-title":"Drug Discov. today"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib101","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1039\/b717821b","article-title":"Leuko-polymersomes","volume":"139","author":"Hammer","year":"2008","journal-title":"Faraday Discuss."},{"issue":"17","key":"10.1016\/j.biomaterials.2017.09.020_bib102","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.1021\/la1017032","article-title":"Tunable leuko-polymersomes that adhere specifically to inflammatory markers","volume":"26","author":"Robbins","year":"2010","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib103","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/bc700212b","article-title":"Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets","volume":"18","author":"Zhu","year":"2007","journal-title":"Bioconjugate Chem."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib104","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0006-2952(03)00387-3","article-title":"P-selectin as a candidate target in atherosclerosis","volume":"66","author":"Molenaar","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"24","key":"10.1016\/j.biomaterials.2017.09.020_bib105","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur. heart J."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib106","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biomaterials.2012.10.004","article-title":"Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages","volume":"34","author":"Park","year":"2013","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib107","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro","year":"2016","journal-title":"Nat. Mater"},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."},{"issue":"13","key":"10.1016\/j.biomaterials.2017.09.020_bib109","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.2174\/1389450115666141109211413","article-title":"Proteomic profiling of a biomimetic drug delivery platform","volume":"16","author":"Corbo","year":"2014","journal-title":"Curr. drug targets"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib110","doi-asserted-by":"crossref","first-page":"34422","DOI":"10.1038\/srep34422","article-title":"Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability","volume":"6","author":"Palomba","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib111","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biomaterials.2015.11.054","article-title":"Cell source determines the immunological impact of biomimetic nanoparticles","volume":"82","author":"Evangelopoulos","year":"2016","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2017.09.020_bib112","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-14-3095","article-title":"Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib113","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib114","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0021-9258(17)35201-8","article-title":"The life span of the human red blood cell","volume":"166","author":"Shemin","year":"1946","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5473","key":"10.1016\/j.biomaterials.2017.09.020_bib115","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib116","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2008-01-134304","article-title":"Deficiency of decay-accelerating factor and complement receptor 1\u2013related gene\/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg","volume":"112","author":"Kim","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib117","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/adhm.201200138","article-title":"Erythrocyte-inspired delivery systems","volume":"1","author":"Hu","year":"2012","journal-title":"Adv. Healthc. Mater."},{"issue":"27","key":"10.1016\/j.biomaterials.2017.09.020_bib118","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/14712598.2012.661710","article-title":"Nanoparticles disguised as red blood cells to evade the immune system","volume":"12","author":"Fang","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib120","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1039\/c3nr00015j","article-title":"Marker-of-self\u2019functionalization of nanoscale particles through a top-down cellular membrane coating approach","volume":"5","author":"Hu","year":"2013","journal-title":"Nanoscale"},{"issue":"26","key":"10.1016\/j.biomaterials.2017.09.020_bib121","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/adma.201300638","article-title":"Surface functionalization of gold nanoparticles with red blood cell membranes","volume":"25","author":"Gao","year":"2013","journal-title":"Adv. Mater."},{"issue":"46","key":"10.1016\/j.biomaterials.2017.09.020_bib122","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1002\/smll.201502388","article-title":"Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance","volume":"11","author":"Rao","year":"2015","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib123","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7150\/thno.14471","article-title":"Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors","volume":"6","author":"Luk","year":"2016","journal-title":"Theranostics"},{"issue":"37","key":"10.1016\/j.biomaterials.2017.09.020_bib124","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nnano.2013.54","article-title":"A\u00a0biomimetic nanosponge that absorbs pore-forming toxins","volume":"8","author":"Hu","year":"2013","journal-title":"Nat. Nano"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib126","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fimmu.2014.00653","article-title":"Emerging evidence for platelets as immune and inflammatory effector cells","volume":"5","author":"Rondina","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib127","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib128","first-page":"181","article-title":"Role of platelets in hemostasis and thrombosis","volume":"125","author":"Rodvien","year":"1976","journal-title":"West J. Med."},{"issue":"5511","key":"10.1016\/j.biomaterials.2017.09.020_bib129","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/255720a0","article-title":"Specific roles for platelet surface glycoproteins in platelet function","volume":"255","author":"Nurden","year":"1975","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib130","first-page":"469","article-title":"Platelet membrane glycoproteins: role in primary hemostasis and component antigens","volume":"63","author":"Beardsley","year":"1990","journal-title":"Yale J. Biol. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib131","first-page":"101","article-title":"A\u00a0liposome based platelet substitute, the plateletsome, with hemostatic efficacy","volume":"21","author":"Rybak","year":"1993","journal-title":"Biomater. Artif. Cells Immobil. Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib132","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.V100.1.136","article-title":"Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia\/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions","volume":"100","author":"Nishiya","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib133","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib134","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","article-title":"Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells","volume":"105","author":"Palumbo","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib136","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1073\/pnas.98.4.1853","article-title":"Integrin activation controls metastasis in human breast cancer","volume":"98","author":"Felding-Habermann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"57","key":"10.1016\/j.biomaterials.2017.09.020_bib137","doi-asserted-by":"crossref","first-page":"46218","DOI":"10.1039\/C5RA05339K","article-title":"Targeted killing of metastatic cells using a platelet-inspired drug delivery system","volume":"5","author":"Pan","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib138","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"issue":"7571","key":"10.1016\/j.biomaterials.2017.09.020_bib139","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.09.020_bib140","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2004-08-2980","article-title":"Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia","volume":"105","author":"Olsson","year":"2005","journal-title":"Blood"},{"issue":"32","key":"10.1016\/j.biomaterials.2017.09.020_bib141","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.1016\/S0021-9258(19)47291-8","article-title":"Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex","volume":"264","author":"Sims","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib142","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.cb.06.110190.001553","article-title":"Platelet membrane glycoproteins: functions in cellular interactions","volume":"6","author":"Kieffer","year":"1990","journal-title":"Annu. Rev. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.09.020_bib143","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrmicro1425","article-title":"The interaction of bacterial pathogens with platelets","volume":"4","author":"Fitzgerald","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.biomaterials.2017.09.020_bib144","doi-asserted-by":"crossref","first-page":"11243","DOI":"10.1021\/nn503732m","article-title":"Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries","volume":"8","author":"Anselmo","year":"2014","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2017.09.020_bib145","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/cm402126n","article-title":"Assembly of layer-by-layer particles and their interactions with biological systems","volume":"26","author":"Yan","year":"2014","journal-title":"Chem. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.09.020_bib146","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrd4503","article-title":"A\u00a0holistic approach to targeting disease with polymeric nanoparticles","volume":"14","author":"Cheng","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.biomaterials.2017.09.020_bib148","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1211\/jpp.60.12.0011","article-title":"Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase","volume":"60","author":"Cui","year":"2008","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.biomaterials.2017.09.020_bib149","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1039\/c2cs15294k","article-title":"Surface functionalization of nanoparticles for nanomedicine","volume":"41","author":"Mout","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.09.020_bib150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib151","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1021\/acsnano.5b06939","article-title":"Blood exosomes endowed with magnetic and targeting properties for cancer therapy","volume":"10","author":"Qi","year":"2016","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.09.020_bib152","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib153","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biomaterials.2017.05.003","article-title":"High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy","volume":"135","author":"Gao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib154","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2147\/IJN.S109059","article-title":"Effects of the protein corona on liposome\u2013liposome and liposome\u2013cell interactions","volume":"11","author":"Corbo","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C6BM00921B","article-title":"Personalized protein corona on nanoparticles and its clinical implications","volume":"5","author":"Corbo","year":"2017","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.09.020_bib156","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6","article-title":"Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics","volume":"39","author":"Luck","year":"1998","journal-title":"J.\u00a0Biomed. Mater Res."},{"issue":"24","key":"10.1016\/j.biomaterials.2017.09.020_bib157","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1002\/smll.201101511","article-title":"Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles","volume":"7","author":"Casals","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib158","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.06.005","article-title":"Issues and concerns in nanotech product development and its commercialization","volume":"193","author":"Kaur","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2017.09.020_bib159","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2017.09.020_bib160","doi-asserted-by":"crossref","unstructured":"A. Waldenstrom, N. Genneback, U. Hellamn, G. Ronquist, Cardiomyocyte microvesicles contain DNA\/RNA and covey biological messages to target cells, PLoS One 7(4) e34653.","DOI":"10.1371\/journal.pone.0034653"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121730604X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121730604X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:28:38Z","timestamp":1758904118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121730604X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":160,"alternative-id":["S014296121730604X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.020","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}